Estia Health Limited provides services in residential aged care homes in Australia.
Estia Health Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$2.49|
|52 Week High||AU$1.28|
|52 Week Low||AU$2.75|
|1 Month Change||8.73%|
|3 Month Change||0%|
|1 Year Change||76.60%|
|3 Year Change||3.32%|
|5 Year Change||-29.06%|
|Change since IPO||-47.47%|
Recent News & Updates
Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
|EHE||AU Healthcare||AU Market|
Return vs Industry: EHE exceeded the Australian Healthcare industry which returned 23.6% over the past year.
Return vs Market: EHE exceeded the Australian Market which returned 27% over the past year.
Stable Share Price: EHE is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: EHE's weekly volatility (5%) has been stable over the past year.
About the Company
Estia Health Limited provides services in residential aged care homes in Australia. The company operates residential aged care homes. As of June 30, 2021, it had 69 homes of which 62 are freehold sites that include 6,289 operational bed licenses in New South Wales, Queensland, South Australia, and Victoria.
Estia Health Fundamentals Summary
|EHE fundamental statistics|
Is EHE overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EHE income statement (TTM)|
|Cost of Revenue||AU$505.16m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.023|
|Net Profit Margin||0.93%|
How did EHE perform over the long term?See historical performance and comparison
0.9%Current Dividend Yield
Is Estia Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: EHE (A$2.49) is trading below our estimate of fair value (A$19.49)
Significantly Below Fair Value: EHE is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: EHE is poor value based on its PE Ratio (108.5x) compared to the Australian Healthcare industry average (26.5x).
PE vs Market: EHE is poor value based on its PE Ratio (108.5x) compared to the Australian market (18.7x).
Price to Earnings Growth Ratio
PEG Ratio: EHE is poor value based on its PEG Ratio (2.7x)
Price to Book Ratio
PB vs Industry: EHE is good value based on its PB Ratio (1.1x) compared to the AU Healthcare industry average (2.4x).
How is Estia Health forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EHE's forecast earnings growth (39.8% per year) is above the savings rate (1.9%).
Earnings vs Market: EHE's earnings (39.8% per year) are forecast to grow faster than the Australian market (11.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: EHE's revenue (3.3% per year) is forecast to grow slower than the Australian market (5.3% per year).
High Growth Revenue: EHE's revenue (3.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EHE's Return on Equity is forecast to be low in 3 years time (5.2%).
How has Estia Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EHE has a large one-off loss of A$5.5M impacting its June 30 2021 financial results.
Growing Profit Margin: EHE became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: EHE's earnings have declined by 50.8% per year over the past 5 years.
Accelerating Growth: EHE has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: EHE has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (61.3%).
Return on Equity
High ROE: EHE's Return on Equity (1%) is considered low.
How is Estia Health's financial position?
Financial Position Analysis
Short Term Liabilities: EHE's short term assets (A$52.0M) do not cover its short term liabilities (A$968.8M).
Long Term Liabilities: EHE's short term assets (A$52.0M) do not cover its long term liabilities (A$281.9M).
Debt to Equity History and Analysis
Debt Level: EHE's debt to equity ratio (18.6%) is considered satisfactory.
Reducing Debt: EHE's debt to equity ratio has reduced from 42.9% to 18.6% over the past 5 years.
Debt Coverage: EHE's debt is well covered by operating cash flow (49.3%).
Interest Coverage: EHE's interest payments on its debt are not well covered by EBIT (1.3x coverage).
What is Estia Health current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: EHE's dividend (0.92%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.3%).
High Dividend: EHE's dividend (0.92%) is low compared to the top 25% of dividend payers in the Australian market (5.41%).
Stability and Growth of Payments
Stable Dividend: EHE is not paying a notable dividend for the Australian market, therefore no need to check if payments are stable.
Growing Dividend: EHE is not paying a notable dividend for the Australian market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: EHE is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. He joined Estia Health in October 2016. Mr. Thorley was the Chief Operating Officer of Esti...
CEO Compensation Analysis
Compensation vs Market: Ian's total compensation ($USD667.36K) is about average for companies of similar size in the Australian market ($USD722.58K).
Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year.
Experienced Management: EHE's management team is considered experienced (2.9 years average tenure).
Experienced Board: EHE's board of directors are considered experienced (4.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: EHE insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Estia Health Limited's employee growth, exchange listings and data sources
- Name: Estia Health Limited
- Ticker: EHE
- Exchange: ASX
- Founded: 2005
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: AU$650.990m
- Shares outstanding: 261.44m
- Website: https://www.estiahealth.com.au
Number of Employees
- Estia Health Limited
- 227 Elizabeth Street
- Level 9
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/18 08:04|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.